000 01303 a2200385 4500
005 20250514065433.0
264 0 _c20030521
008 200305s 0 0 eng d
022 _a0954-6111
024 7 _a10.1053/rmed.2002.1471
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBallmann, M
245 0 0 _aLow-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis.
_h[electronic resource]
260 _bRespiratory medicine
_cMay 2003
300 _a498-500 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCystic Fibrosis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aForced Expiratory Volume
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aPneumonia
_xdrug therapy
650 0 4 _aRetrospective Studies
700 1 _aJunge, S
700 1 _avon der Hardt, H
773 0 _tRespiratory medicine
_gvol. 97
_gno. 5
_gp. 498-500
856 4 0 _uhttps://doi.org/10.1053/rmed.2002.1471
_zAvailable from publisher's website
999 _c12524597
_d12524597